Theraly Fibrosis, Inc. — Form D
Theraly Fibrosis, Inc. of GERMANTOWN, MD, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-22. The offering totals $5.0M, of which $4.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-06-22
- Form: D
- Accession: 0001733346-18-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.9M
- Remaining: $57K
- Investors: 4
- Date of first sale: 2018-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315205
Issuer
- Name: Theraly Fibrosis, Inc.
- CIK: 0001733346
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 20271 GOLDENROD ROAD, SUITE 2097, GERMANTOWN, MD, 20876
- Phone: 3015026621
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Seulki Lee | Director | Seongnam-si, M5 |
| Junghee Lim | Director | Germantown, MD |
| Keele Park | Director | Germantown, MD |
| Viktor Roschke | Director | Germantown, MD |
| Viktor Roschke | Executive Officer | Germantown, MD |
Other filings by this issuer (1)
More